Phase II study of zolbetuximab plus pembrolizumab in claudin 18.2: Positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ)-ILUSTRO Cohort 3 Meeting Abstract
| Authors: | Klempner, S. J.; Ajani, J. A.; Al-Batran, S. E.; Bang, Y. J.; Catenacci, D. V. T.; Enzinger, P. C.; Ilson, D. H.; Kim, S.; Lordick, F.; Shah, M. A.; Shitara, K.; Arozullah, A.; Park, J. W.; Raizer, J. J.; Van Cutsem, E.; Xu, R. H. |
| Abstract Title: | Phase II study of zolbetuximab plus pembrolizumab in claudin 18.2: Positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ)-ILUSTRO Cohort 3 |
| Meeting Title: | 2021 Gastrointestinal Cancers Symposium (ASCO GI) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 15-17 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-01-20 |
| Language: | English |
| ACCESSION: | WOS:000636712800028 |
| DOI: | 10.1200/JCO.2021.39.3_suppl.TPS260 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS260 -- Source: Wos |
